Autoimmune hypophysitis: Expanding the differential diagnosis to CTLA-4 blockade

Expert Review of Endocrinology and Metabolism

Volumn 4, Issue 6, 2009, Pages 681-698

  Gutenberg, Angelika ^b   Landek Salgado, Melissa ^a   Tzou, Shey Cherng ^a   Lupi, Isabella ^c   Geis, Abby ^a   Kimura, Hiroaki ^a   Caturegli, Patrizio ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF PISA   (Italy)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Autoimmunity; CTLA 4 blockade; Hypophysitis; Monoclonal antibodies; MRI; Nonfunctioning sellar masses

Indexed keywords

AZATHIOPRINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FORKHEAD TRANSCRIPTION FACTOR; GLUCOCORTICOID; IPILIMUMAB; METHOTREXATE; PREDNISOLONE; RITUXIMAB; TICILIMUMAB;

ANTIGEN PRESENTING CELL; ARACHNOID CYST; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL FEATURE; CLINICAL TRIAL; CRANIOPHARYNGIOMA; CYTOTOXICITY; DENDRITIC CELL; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DRUG DOSE REDUCTION; DRUG MEGADOSE; EFFECTOR CELL; EPIDERMOID CYST; GAMMA KNIFE RADIOSURGERY; GENETIC ASSOCIATION; GEOGRAPHIC DISTRIBUTION; GERM CELL TUMOR; HEADACHE; HISTIOCYTOSIS X; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS DISEASE; HYPOPHYSITIS; IMMUNOSURVEILLANCE; LYMPHOCYTE FUNCTION; LYMPHOMA; MELANOMA; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RATHKE CLEFT CYST; REVIEW; SARCOIDOSIS; SEX DIFFERENCE; STEREOTACTIC RADIOSURGERY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; VISUAL DISORDER; WEGENER GRANULOMATOSIS;

EID: 70449941268     PISSN: 17446651     EISSN: None     Source Type: Journal    
DOI: 10.1586/eem.09.37     Document Type: Review

References (190)

1. Caturegli PC, Newschaffer A, Olivi MG, Pomper PC, Burger, Rose NR. Autoimmune hypophysitis. Endocr. Rev. 26(5), 599-614 (2005).
2. De Bellis, AG, Ruocco, M Battaglia et al. Immunological and clinical aspects of lymphocytic hypophysitis. Clin. Sci. (Lond.) 114(6), 413-421 (2008).
3. Gutenberg AR, Buslei R, Fahlbusch R, Buchfelder M, Bruck W. Immunopathology of primary hypophysitis: implications for pathogenesis. Am. J. Surg. Pathol. 29(3), 329-338 (2005). (Pubitemid 40321968)
4. Folkerth RD, Price DL Jr, Schwartz M, Black PM, Girolami U De. Xanthomatous hypophysitis. Am. J. Surg. Pathol. 22(6), 736-741 (1998).
5. Burt MG, Morey AL, Turner JJ, Pell M, Sheehy JP, Ho KK. Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary 6(3), 161-168 (2003).
6. Cheung CC, Ezzat S, Smyth HS, Asa SL. The spectrum and significance of primary hypophysitis. J. Clin. Endocrinol. Metab. 86(3), 1048-1053 (2001).
7. Deodhare SS, Bilbao JM, Kovacs K et al. Xanthomatous hypophysitis: a novel entity of obscure etiology. Endocr. Pathol. 10(3), 237-241 (1999).
8. Tashiro T, Sano T, Xu B et al. Spectrum of different types of hypophysitis: a clinicopathologic study of hypophysitis in 31 cases. Endocr. Pathol. 13(3), 183-195 (2002). (Pubitemid 36021030)
9. Gutenberg A, Bell JJ, Lupi I et al. Pituitary and systemic autoimmunity in a case of intrasellar germinoma. Pituitary DOI: 10.1007/s11102-009-0187-x (2009) (Epub ahead of print).
10. Janeczko, C, McHugh J, Rawluk D, Farrell M, Brennan P, Delanty N. Hypophysitis secondary to ruptured Rathke's cyst mimicking neurosarcoidosis. J. Clin. Neurosci. 16(4), 599-600 (2009).
11. Cuthbertson DJ, Ritchie D, Crooks D et al. Lymphocytic hypophysitis occurring simultaneously with a functioning pituitary adenoma. Endocr. J. 55(4), 729-735 (2008).
12. Puchner MJ, Ludecke DK, Saeger W. The anterior pituitary lobe in patients with cystic craniopharyngiomas: three cases of associated lymphocytic hypophysitis. Acta Neurochir. (Wien) 126(1), 38-43 (1994). (Pubitemid 24027540)
13. McIntyre EA, Perros P. Fatal inflammatory hypophysitis. Pituitary 10(1), 107-111 (2007).
14. Takano, K. Sarcoidosis of the hypothalamus and pituitary. Intern. Med. 43(10), 894-895 (2004).
15. Kaltsas GA, Powles TB, J Evanson et al. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J. Clin. Endocrinol. Metab. 85(4), 1370-1376 (2000).
16. Rao S, Rajkumar A, Kuruvilla S. Sellar lesion: not always a pituitary adenoma. Indian J. Pathol. Microbiol. 51(2), 269-270 (2008).
17. Dillard T, Yedinak CG, Alumkal J, Fleseriu M. Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes. Pituitary DOI: 10.1007/s11102-009- 0193-z (2009) (Epub ahead of print).
18. Goudie RB, Pinkerton PH. Anterior hypophysitis and Hashimoto's disease in a woman. J. Pathol. Bacteriol. 83, 584-585 (1962).
19. Mayfield RK, Levine JH, Gordon L, Powers J, Galbraith RM, Rawe SE. Lymphoid adenohypophysitis presenting as a pituitary tumor. Am. J. Med. 69, 619-623 (1980). (Pubitemid 10018720)
20. Quencer RM. Lymphocytic adenohypophysitis: autoimmune disorder of the pituitary gland. AJNR Am J. Neuroradiol. 1(4), 343-345 (1980).
21. Levine SN, Benzel EC, Fowler MR, Shroyer JV, Mirfakhraee M. Lymphocytic adenohypophysitis: clinical, radiological, and magnetic resonance imaging characterization. Neurosurgery 22(5), 937-941 (1988). (Pubitemid 18131862)
22. Bellastella A, Bizzarro A, Coronella C, Bellastella G, Sinisi AA, De Bellis A. Lymphocytic hypophysitis: a rare or underestimated disease? Eur. J. Endocrinol. 149(5), 363-376 (2003). (Pubitemid 37461516)
23. Gutenberg A, Hans V, Puchner MJ et al. Primary hypophysitis: clinical-pathological correlations. Eur. J. Endocrinol. 155(1), 101-107 (2006).
24. Tsagarakis S, Vassiliadi D, Malagari K, Kontogeorgos G, Thalassinos N. Lymphocytic hypophysitis: late recurrence following successful transsphenoidal surgery. Endocrine 25(2), 85-90 (2004). (Pubitemid 41271132)
25. Lecube A, Francisco G, Rodriguez D et al. Lymphocytic hypophysitis successfully treated with azathioprine: first case report. J. Neurol. Neurosurg. Psychiatry 74(11), 1581-1583 (2003). (Pubitemid 37392886)
26. Leung GK, Lopes MB, Thorner MO, Vance ML, Laws ER. Primary hypophysitis: a single-center experience in 16 cases. J. Neurosurg. 101(2), 262-271 (2004).
27. Tubridy N, Saunders D, Thom M et al. Infundibulohypophysitis in a man presenting with diabetes insipidus and cavernous sinus involvement. J. Neurol. Neurosurg. Psychiatry 71(6), 798-801 (2001). (Pubitemid 33121926)
28. Postema PTE, van Hagen PM, de Herder WW. Treatment of aggressive, recurrent lymphocytic hypophysitis with rituximab. Presented at: 90th Annual Meeting of the Endocrine Society. San Francisco, CA, USA, 12-15 June 2008 (Abstract P1-394).
29. Selch MT, DeSalles AA, Kelly DF et al. Stereotactic radiotherapy for the treatment of lymphocytic hypophysitis. Report of two cases. J. Neurosurg. 99(3), 591-596 (2003).
30. Ray DK, Yen CP, Vance ML, Laws ER, Lopes B, Sheehan JP. g knife surgery for lymphocytic hypophysitis. Neurosurg. J. DOI: 10.3171/2009.6.JNS081176 (2009) (Epub ahead of print).
31. Gonzalez-Cuyar LF, Tavora F, Shaw K, Castellani RJ, Dejong JL. Sudden unexpected death in lymphocytic hypophysitis. Am. J. Forensic Med. Pathol. 30(1), 61-63 (2009).
32. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer Immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3(11), 991-998 (2002).
33. Choudhury A, Mosolits S, Kokhaei P, Hansson L, Palma M, Mellstedt H. Clinical results of vaccine therapy for cancer: learning from history for improving the future. Adv. Cancer Res. 95, 147-202 (2006). (Pubitemid 44066526)
34. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711 (2003).
35. Serafini P, Borrello I, Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 16(1), 53-65 (2006). (Pubitemid 43139709)
36. Lucas T, Abraham D, Aharinejad S. Modulation of tumor associated macrophages in solid tumors. Front. Biosci. 13, 5580-5588 (2008).
37. Kryczek I, Liu R, Wang G et al. FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res. 69(9), 3995-4000 (2009).
38. Oble DA, Loewe R, Yu P, Mihm MC Jr. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun. 9, 3 (2009).
39. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu. Rev. Immunol. 23, 515-548 (2005).
40. Subudhi SK, Alegre ML, Fu YX. The balance of immune responses: costimulation verse coinhibition. J. Mol. Med. 83(3), 193-202 (2005).
41. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3(5), 541-547 (1995).
42. Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423(6939), 506-511 (2003). (Pubitemid 36648570)
43. Melero I, Hervas-Stubbs S, Glennie M, Pardoll DM, Chen L. Immunostimulatory monoclonal antibodies for cancer therapy. Nat. Rev. Cancer 7(2), 95-106 (2007). (Pubitemid 46160986)
44. Beck KE, Blansfield JA, Tran KQ et al. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J. Clin. Oncol. 24(15), 2283-2289 (2006).
45. Hodi FS, Mihm MC, Soiffer RJ et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc. Natl Acad. Sci. USA 100(8), 4712-4717 (2003).
46. Phan GQ, Yang JC, Sherry RM et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl Acad. Sci. USA 100(14), 8372-8377 (2003).
47. Weber JS. The clinical utility of cytotoxic T lymphocyte antigen 4 abrogation by human antibodies. Melanoma Res. 16(5), 379-383 (2006).
48. Weber J. Ipilimumab: controversies in its development, utility and autoimmune adverse events. Cancer Immunol. Immunother. 58(5), 823-830 (2009).
49. Maker AV, Attia P, Rosenberg SA. Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade. J. Immunol. 175(11), 7746-7754 (2005). (Pubitemid 41713475)
50. + regulatory T cell function. Science 322(5899), 271-275 (2008).
51. Hodi FS. Cytotoxic T-lymphocyteassociated antigen-4. Clin. Cancer Res. 13(18 Pt 1), 5238-5242 (2007).
52. Weber J. Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events. Oncologist 12(7), 864-872 (2007). (Pubitemid 47328229)
53. Blansfield JA, Beck KE, Tran K et al. Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J. Immunother. 28(6), 593-598 (2005). (Pubitemid 41533093)
54. Yang JC, Hughes M, Kammula U et al. Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis. J. Immunother. 30(8), 825-830 (2007). (Pubitemid 350295361)
55. Weber JS, O'Day S, Urba W et al. Phase I/II study of ipilimumab for patients with metastatic melanoma. J. Clin. Oncol. 26(36), 5950-5956 (2008).
56. Maker AV, Yang JC, Sherry RM et al. Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma. J. Immunother. 29(4), 455-463 (2006).
57. Carpenter KJ, Murtagh RD, Lilienfeld H, Weber J, Murtagh FR. Ipilimumab-induced hypophysitis: MR imaging Findings. AJNR Am. J. Neuroradiol. 30(9), 1751-1753 (2009).
58. Kaehler KC, Egberts F, Lorigan P, Hauschild A. Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient. Melanoma Res. 19(5), 333-334 (2009).
59. Shaw SA, Camacho LH, McCutcheon IE, Waguespack SG. Transient hypophysitis after cytotoxic T lymphocyte-associated antigen 4 (CTLA4) blockade. J. Clin. Endocrinol. Metab. 92(4), 1201-1202 (2007).
60. Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol. Metab. Clin. North Am. 28(1), 81-117 (1999).
61. Glezer A, Paraiba DB, Bronstein MD. Rare sellar lesions. Endocrinol. Metab. Clin. North Am. 37(1), 195-211 (2008).
62. Caturegli P. Autoimmune hypophysitis: an underestimated disease in search of its autoantigen(s). J. Clin. Endocrinol. Metab. 92(6), 2038-2040 (2007). (Pubitemid 46997097)
63. Tzou SC, Lupi I, Landek M et al. Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model. Endocrinology 149(7), 3461-3469 (2008). (Pubitemid 351919586)
64. Lidove O, Piette JC, Charlotte F, Cassoux N, Correas JM, Papo T. Lymphocytic hypophysitis with lachrymal, salivary and thyroid gland involvement. Eur. J. Intern. Med. 15(2), 121-124 (2004). (Pubitemid 38692688)
65. Guay AT, Agnello V, Tronic BC, Gresham DG, Freidberg SR. Lymphocytic hypophysitis in a man. J. Clin. Endocrinol. Metab. 64(3), 631-634 (1987).
66. Cosman F, Post KD, Holub DA, Wardlaw SL. Lymphocytic hypophysitis. Report of 3 new cases and review of the literature. Medicine 68(4), 240-256 (1989). (Pubitemid 19186161)
67. Gutenberg A, Larsen J, Lupi I, Rohde V, Caturegli P. A radiological score to distinguish autoimmune hypophysitis from non-secreting pituitary adenoma preoperatively. AJNR Am. J. Neuroradiol. 30(9), 1766-1772 (2009).
68. Ahmadi J, Meyers GS, Segall HD, Sharma OP, Hinton DR. Lymphocytic adenohypophysitis: contrast-enhanced MR imaging in five cases. Radiology 195(1), 30-34 (1995).
69. Lee MH, Choi HY, Sung YA, Lee JK. High signal intensity of the posterior pituitary gland on T1-weighted MR images. Correlation with plasma vasopressin concentration to water deprivation. Acta Radiol. 42(2), 129-134 (2001).
70. Chanson P, Brochier S. Non-functioning pituitary adenomas. J. Endocrinol. Invest. 28(11 Suppl.), 93-99 (2005).
71. Asa SL. Practical pituitary pathology: what does the pathologist need to know? Arch. Pathol. Lab. Med. 132(8), 1231-1240 (2008).
72. Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary tumor registry. Eur. J. Endocrinol. 156(2), 203-216 (2007). (Pubitemid 46554515)
73. Drange MR, Fram NR, Herman-Bonert V, Melmed S. Pituitary tumor registry: a novel clinical resource. J. Clin. Endocrinol. Metab. 85(1), 168-174 (2000). (Pubitemid 32268809)
74. Lamberts SW, de Herder WW, van der Lely AJ. Pituitary insufficiency. Lancet 352(9122), 127-134 (1998).
75. Ferrante E, Ferraroni M, Castrignano T et al. Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur. J. Endocrinol. 155(6), 823-829 (2006). (Pubitemid 46040620)
76. Choi SH, Kwon BJ, Na DG, Kim JH, Han MH, Chang KH. Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI. Clin. Radiol. 62(5), 453-462 (2007).
77. Heshmati HM, Kujas M, Casanova S et al. Prevalence of lymphocytic infiltrate in 1400 pituitary adenomas. Endocr. J. 45(3), 357-361 (1998). (Pubitemid 128508708)
78. Rao VJ, James RA, Mitra D. Imaging characteristics of common suprasellar lesions with emphasis on MRI findings. Clin. Radiol. 63(8), 939-947 (2008).
79. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J. Neurosurg. 89(4), 547-551 (1998).
80. Garnett MR, Puget S, Grill J, Sainte-Rose C. Craniopharyngioma. Orphanet J. Rare Dis. 2, 18 (2007).
81. Shin JL, Asa SL, Woodhouse LJ, Smyth HS, Ezzat S. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke's cleft cyst, and arachnoid cyst. J. Clin. Endocrinol. Metab. 84(11), 3972-3982 (1999). (Pubitemid 30644182)
82. Karavitaki N, Cudlip S, Adams CB, Wass JA. Craniopharyngiomas. Endocr. Rev. 27(4), 371-397 (2006).
83. Van Effenterre R, Boch AL. Craniopharyngioma in adults and children: a study of 122 surgical cases. J. Neurosurg. 97(1), 3-11 (2002). (Pubitemid 34693694)
84. Voelker JL, Campbell RL, Muller J. Clinical, radiographic, and pathological features of symptomatic Rathke's cleft cysts. J. Neurosurg. 74(4), 535-544 (1991).
85. Kasperbauer JL, Orvidas LJ, Atkinson JL, Abboud CF. Rathke cleft cyst: diagnostic and therapeutic considerations. Laryngoscope 112(10), 1836-1839 (2002).
86. Osborn AG, Preece MT. Intracranial cysts: radiologic-pathologic correlation and imaging approach. Radiology 239(3), 650-664 (2006).
87. Rengachary SS, Watanabe I. Ultrastructure and pathogenesis of intracranial arachnoid cysts. J. Neuropathol. Exp. Neurol. 40(1), 61-83 (1981). (Pubitemid 11138527)
88. Harrison MJ, Morgello S, Post KD. Epithelial cystic lesions of the sellar and parasellar region: a continuum of ectodermal derivatives? J. Neurosurg. 80(6), 1018-1025 (1994). (Pubitemid 24154179)
89. Dubuisson AS, Stevenaert A, Martin DH, Flandroy PP. Intrasellar arachnoid cysts. Neurosurgery 61(3), 505-513 (2007).
90. Mohn A, Schoof E, Fahlbusch R, Wenzel D, Dorr HG. The endocrine spectrum of arachnoid cysts in childhood. Pediatr. Neurosurg. 31(6), 316-321 (1999). (Pubitemid 30151559)
91. Kaido T, Okazaki A, Kurokawa S, Tsukamoto M. Pathogenesis of intraparenchymal epidermoid cyst in the brain: a case report and review of the literature. Surg. Neurol. 59(3), 211-216 (2003). (Pubitemid 36390215)
92. Green AJ, Roberts DR, Swanson RA. Post-traumatic epidermoid cyst presenting with headache. Neurology 64(9), 1657 (2005).
93. Yamakawa K, Shitara N, Genka S, Manaka S, Takakura K. Clinical course and surgical prognosis of 33 cases of intracranial epidermoid tumors. Neurosurgery 24(4), 568-573 (1989). (Pubitemid 19094792)
94. Oge K, Ozgen T. Transsphenoidal removal of an intra- and suprasellar epidermoid cyst. Neurochirurgia (Stuttg.) 34(3), 94-96 (1991).
95. Huang BY, Castillo M. Nonadenomatous tumors of the pituitary and sella turcica. Top. Magn. Reson. Imaging 16(4), 289-299 (2005). (Pubitemid 44350376)
96. Kinjo T, al-Mefty O, Ciric I. Diaphragma sellae meningiomas. Neurosurgery 36(6), 1082-1092 (1995).
97. Gokalp HZ, Arasil E, Kanpolat Y, Balim T. Meningiomas of the tuberculum sella. Neurosurg. Rev. 16(2), 111-114 (1993).
98. Schick U, Hassler W. Surgical management of tuberculum sellae meningiomas: involvement of the optic canal and visual outcome. J. Neurol. Neurosurg. Psychiatry 76(7), 977-983 (2005). (Pubitemid 40909556)
99. Ebner FH, Bornemann A, Wilhelm H, Ernemann U, Honegger J. Tuberculum sellae meningioma symptomatic during pregnancy: pathophysiological considerations. Acta Neurochir. (Wien) 150(2), 189-193 (2008).
100. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ. Sex steroid hormone exposures and risk for meningioma. J. Neurosurg. 99(5), 848-853 (2003).
101. Nakamura M, Roser F, Struck M, Vorkapic P, Samii M. Tuberculum sellae meningiomas: clinical outcome considering different surgical approaches. Neurosurgery 59(5), 1019-1028(2006). (Pubitemid 44852077)
102. Kuo JS, Yu C, Giannotta SL, Petrovich Z, Apuzzo ML. The Leksell g knife Model U versus Model C: a quantitative comparison of radiosurgical treatment parameters. Neurosurgery 55(1), 168-172 (2004). (Pubitemid 38859100)
103. Donovan JL, Nesbit GM. Distinction of masses involving the sella and suprasellar space: specificity of imaging features. AJR Am. J. Roentgenol. 167(3), 597-603 (1996).
104. Dahlin DC, Maccarty CS. Chordoma. Cancer 5(6), 1170-1178 (1952).
105. Erdem E, Angtuaco EC, Van Hemert R, Park JS, Al-Mefty O. Comprehensive review of intracranial chordoma. Radiographics 23(4), 995-1009 (2003).
106. McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control 12(1), 1-11 (2001).
107. Thodou E, Kontogeorgos G, Scheithauer BW et al. Intrasellar chordomas mimicking pituitary adenoma. J. Neurosurg. 92(6), 976-982 (2000). (Pubitemid 30346516)
108. Bonneville F, Narboux Y, Cattin F, Rodiere E, Jacquet G, Bonneville JF. Preoperative location of the pituitary bright spot in patients with pituitary macroadenomas. AJNR Am. J. Neuroradiol. 23(4), 528-532 (2002). (Pubitemid 34411903)
109. Doucet V, Peretti-Viton P, Figarella- Branger D, Manera L, Salamon G. MRI of intracranial chordomas. Extent of tumour and contrast enhancement: criteria for differential diagnosis. Neuroradiology 39(8), 571-576 (1997). (Pubitemid 27338542)
110. Sze G, Uichanco LS 3rd, Brant-Zawadzki MN et al. Chordomas: MR imaging. Radiology 166(1 Pt 1), 187-191 (1988).
111. Hermet M, Delevaux I, Trouillier S, Andre M, Chazal J, Aumaitre O. [Pituitary metastasis presenting as diabetes insipidus: a report of four cases and literature review]. Rev. Med. Interne 30(5), 425-429 (2009).
112. Komninos J, Vlassopoulou V, Protopapa D et al. Tumors metastatic to the pituitary gland: case report and literature review. J. Clin. Endocrinol. Metab. 89(2), 574-580 (2004). (Pubitemid 38269860)
113. Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the central brain tumor registry of the United States, 1990-1994. Neuro Oncol. 1(1), 14-25 (1999).
114. Inamura T, Nishio S, Ikezaki K, Fukui M. Human chorionic gonadotrophin in CSF, not serum, predicts outcome in germinoma. J. Neurol. Neurosurg. Psychiatry 66(5), 654-657 (1999). (Pubitemid 29186976)
115. Jennings MT, Gelman R, Hochberg F. Intracranial germ-cell tumors: natural history and pathogenesis. J. Neurosurg. 63(2), 155-167 (1985). (Pubitemid 15246078)
116. Frank G, Galassi E, Fabrizi AP, Frank F, Manetto V. Primary intrasellar germinoma: case report. Neurosurgery 30(5), 786-788 (1992).
117. Fields JN, Fulling KH, Thomas PR, Marks JE. Suprasellar germinoma: radiation therapy. Radiology 164(1), 247-249 (1987).
118. Kanagaki M, Miki Y, Takahashi JA et al. MRI and CT findings of neurohypophyseal germinoma. Eur. J. Radiol. 49(3), 204-211 (2004).
119. Nada R, Mohan H, Dhir SP, Mukherjee KK, Kak VK. Suprasellar malignant mixed germ cell tumour presenting as craniopharyngioma. Neurol. India 48(4), 381-384 (2000). (Pubitemid 32094208)
120. Oka H, Kawano N, Tanaka T et al. Long-term functional outcome of suprasellar germinomas: usefulness and limitations of radiotherapy. J. Neurooncol. 40(2), 185-190 (1998). (Pubitemid 29010172)
121. Bamberg M, Kortmann RD, Calaminus G et al. Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J. Clin. Oncol. 17(8), 2585-2592 (1999). (Pubitemid 29368262)
122. Shibamoto Y, Takahashi M, Sasai K. Prognosis of intracranial germinoma with syncytiotrophoblastic giant cells treated by radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 37(3), 505-510 (1997). (Pubitemid 27175302)
123. Utsuki S, Kawano N, Oka H, Tanaka T, Suwa T, Fujii K. Cerebral germinoma with syncytiotrophoblastic giant cells: feasibility of predicting prognosis using the serum hCG level. Acta Neurochir. (Wien) 141(9), 975-977 (1999).
124. Bettendorf M, Fehn M, Grulich-Henn J et al. Lymphocytic hypophysitis with central diabetes insipidus and consequent panhypopituitarism preceding a multifocal, intracranial germinoma in a prepubertal girl. Eur. J. Pediatr. 158(4), 288-292 (1999).
125. Endo T, Kumabe T, Ikeda H, Shirane R, Yoshimoto T. Neurohypophyseal germinoma histologically misidentified as granulomatous hypophysitis. Acta Neurochir. (Wien) 144(11), 1233-1237 (2002).
126. Fehn M, Bettendorf M, Ludecke DK, Sommer C, Saeger W. Lymphocytic hypophysitis masking a suprasellar germinoma in a 12-year-old girl. A case report. Pituitary 1(3-4), 303-307 (1999).
127. Houdouin L, Polivka M, Henegar C, Blanquet A, Delalande O, Mikol J. Pituitary germinoma and lymphocytic hypophysitis: a pitfall. Report of two cases. Ann. Pathol. 23(4), 349-354 (2003). (Pubitemid 37279905)
128. Kim G, Park SA, Hwang HJ et al. A case of suprasellar germinoma misdiagnosed as lymphocytic hypophysitis. J. Korean Med. Sci. 73(2), 210-215 (2007).
129. Mikami-Terao Y, Akiyama M, Yanagisawa T et al. Lymphocytic hypophysitis with central diabetes insipidus and subsequent hypopituitarism masking a suprasellar germinoma in a 13-year-old girl. Childs Nerv. Syst. 22(10), 1338-1343 (2006). (Pubitemid 44446051)
130. Ozbey N, Sencer A, Tanyolac S et al. An intrasellar germinoma with normal cerebrospinal fluid b-HCG concentrations misdiagnosed as hypophysitis. Hormones (Athens) 5(1), 67-71 (2006).
131. Torremocha F, Hadjadj S, Menet E et al. Pituitary germinoma presenting as a pseudotumoral lymphocytic hypophysitis in a man. Ann. Endocrinol. (Paris) 63(1), 13-17 (2002). (Pubitemid 34219607)
132. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann. Intern. Med. 119(11), 1093-1104 (1993).
133. Giustina A, Gola M, Doga M, Rosei EA. Clinical review 136: primary lymphoma of the pituitary: an emerging clinical entity. J. Clin. Endocrinol. Metab. 86(10), 4567-4575 (2001). (Pubitemid 33020487)
134. Johnson BA, Fram EK, Johnson PC, Jacobowitz R. The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features. AJNR Am. J. Neuroradiol. 18(3), 563-572 (1997). (Pubitemid 27154579)
135. Singh S, Cherian RS, George B, Nair S, Srivastava A. Unusual extra-axial central nervous system involvement of non-Hodgkin's lymphoma: magnetic resonance imaging. Australas. Radiol. 44(1), 112-114 (2000). (Pubitemid 30184998)
136. Nelson DF, Martz KL, Bonner H et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology group (RTOG): RTOG 8315. Int. J. Radiat. Oncol. Biol. Phys. 23(1), 9-17 (1992).
137. DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group study 93-10. J. Clin. Oncol. 20(24), 4643-4648 (2002). (Pubitemid 36025280)
138. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am. J. Epidemiol. 145(3), 234-241 (1997). (Pubitemid 27057175)
139. Christoforidis GA, Spickler EM, Recio MV, Mehta BM. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR Am. J. Neuroradiol. 20(4), 655-669 (1999).
140. Porter N, Beynon HL, Randeva HS. Endocrine and reproductive manifestations of sarcoidosis. QJM 96(8), 553-561 (2003).
141. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch. Neurol. 42(9), 909-917 (1985).
142. Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJNR Am. J. Neuroradiol. 11(5), 915-923 (1990).
143. Loh KC, Green A, Dillon WP Jr, Fitzgerald PA, Weidner N, Tyrrell JB. Diabetes insipidus from sarcoidosis confined to the posterior pituitary. Eur. J. Endocrinol. 137(5), 514-519 (1997). (Pubitemid 27505312)
144. Stuart CA, Neelon FA, Lebovitz HE. Hypothalamic insufficiency: the cause of hypopituitarism in sarcoidosis. Ann. Intern. Med. 88(5), 589-594 (1978).
145. Bihan H, Christozova V, JL Dumas et al. Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature. Medicine (Baltimore) 86(5), 259-268 (2007). (Pubitemid 47415004)
146. Bullmann C, Faust M, A Hoffmann et al. Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis. Eur. J. Endocrinol. 142(4), 365-372 (2000). (Pubitemid 30230762)
147. Nowak DA, Widenka DC. Neurosarcoidosis: a review of its intracranial manifestation. J. Neurol. 248(5), 363-372 (2001).
148. Scott TF, Yandora K, Valeri A, Chieffe C, Schramke C. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch. Neurol. 64(5), 691-696 (2007). (Pubitemid 46789835)
149. Inaba H, Suzuki S, Shigematsu S, Kobayashi S, Nishio S, Hashizume K. Spontaneous remission of diabetes insipidus due to CNS sarcoidosis. Intern. Med. 48(4), 225-229 (2009).
150. Guoth MS, Kim J, de Lotbiniere AC, Brines ML. Neurosarcoidosis presenting as hypopituitarism and a cystic pituitary mass. Am. J. Med. Sci. 315(3), 220-224 (1998). (Pubitemid 28125614)
151. Sato N, Sze G, Kim JH. Cystic pituitary mass in neurosarcoidosis. AJNR Am. J. Neuroradiol. 18(6), 1182-1185 (1997).
152. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann. Intern. Med. 123(12), 925-932 (1995).
153. Abdou NI, Kullman GJ, Hoffman GS et al. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s. J. Rheumatol. 29(2), 309-316 (2002).
154. de Groot K, Gross WL, Herlyn K, and Reinhold-Keller E. Development and validation of a disease extent index for Wegener's granulomatosis. Clin. Nephrol. 55(1), 31-38 (2001). (Pubitemid 32041780)
155. Murphy JM, Gomez-Anson B, Gillard JH et al. Wegener granulomatosis: MR imaging findings in brain and meninges. Radiology 213(3), 794-799 (1999).
156. Anderson G, Coles ET, Crane M et al. Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. QJM 83(302), 427-438 (1992).
157. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann. Neurol. 33(1), 4-9 (1993). (Pubitemid 23009903)
158. Goyal M, Kucharczyk W, Keystone E. Granulomatous hypophysitis due to Wegener's granulomatosis. AJNR Am. J. Neuroradiol. 21(8), 1466-1469 (2000).
159. Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ. Pituitary involvement by Wegener's granulomatosis: a report of two cases. AJNR Am. J. Neuroradiol. 20(3), 519-523 (1999). (Pubitemid 30429062)
160. Roberts GA, Eren E, Sinclair H et al. Two cases of Wegener's granulomatosis involving the pituitary. Clin. Endocrinol. (Oxf.) 42(3), 323-328 (1995).
161. Rosete A, Cabral AR, Kraus A, Alarcon-Segovia D. Diabetes insipidus secondary to Wegener's granulomatosis: report and review of the literature. J. Rheumatol. 18(5), 761-765 (1991).
162. Inoue T, Kaneko Y, Mannoji H, Fukui M. Giant cell granulomatous hypophysitis manifesting as an intrasellar mass with unilateral ophthalmoplegia - case report. Neurol. Med. Chir. (Tokyo) 37(10), 766-770 (1997). (Pubitemid 27486143)
163. Yasuhara T, Fukuhara T, Nakagawa M et al. Wegener granulomatosis manifesting as meningitis. Case report. J. Neurosurg. 97(5), 1229-1232 (2002).
164. White ES, Lynch JP. Pharmacological therapy for Wegener's granulomatosis. Drugs 66(9), 1209-1228 (2006).
165. Garovic VD, Clarke BL, Chilson TS, Specks U. Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener's granulomatosis. Am. J. Kidney Dis. 37(1), E5 (2001).
166. Arico M, Clementi R, Caselli D, Danesino C. Histiocytic disorders. Hematol. J. 4(3), 171-179 (2003).
167. Watanabe R, Tatsumi K, Hashimoto S, Tamakoshi A, Kuriyama T. Clinico-epidemiological features of pulmonary histiocytosis X. Intern. Med. 40(10), 998-1003 (2001).
168. Arico M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol. Oncol. Clin. North Am. 12(2), 247-258 (1998). (Pubitemid 28175878)
169. Makras P, Samara C, Antoniou M et al. Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH). Neuroradiology 48(1), 37-44 (2006). (Pubitemid 43336691)
170. Maghnie M, Bossi G, Klersy C, Cosi G, Genovese E, Arico M. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis. J. Clin. Endocrinol. Metab. 83(9), 3089-3094 (1998).
171. Broadbent V, Gadner H. Current therapy for Langerhans cell histiocytosis. Hematol. Oncol. Clin. North Am. 12(2), 327-338 (1998). (Pubitemid 28175883)
172. Thompson LD, Wenig BM, Adair CF, Smith BC, Heffess CS. Langerhans cell histiocytosis of the thyroid: a series of seven cases and a review of the literature. Mod. Pathol. 9(2), 145-149 (1996).
173. Maghnie M, Arico M, Villa A, Genovese E, Beluffi G, Severi F. MR of the hypothalamic-pituitary axis in Langerhans cell histiocytosis. AJNR Am. J. Neuroradiol. 13(5), 1365-1371 (1992).
174. Prayer D, Grois N, Prosch H, Gadner H, Barkovich AJ. MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. AJNR Am. J. Neuroradiol. 25(5), 880-891 (2004). (Pubitemid 38657683)
175. da Rocha AJ, Maia AC Jr, Ferreira NP, do Amaral LL. Granulomatous
176. Sunil K, Menon R, Goel N et al. Pituitary tuberculosis. J. Assoc. Physicians India 55, 453-456 (2007).
177. Arunkumar MJ, Rajshekhar V. Intrasellar tuberculoma presenting as pituitary apoplexy. Neurol. India 49(4), 407-410 (2001). (Pubitemid 34116290)
178. Singh S. Pituitary tuberculoma: magnetic resonance imaging. Neurol. India 51(4), 548-550 (2003). (Pubitemid 38195936)
179. Katti MK. Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis. Med. Sci. Monit. 10(9), RA215-RA229 (2004).
180. Patankar T, Patkar D, Bunting T, Castillo M, Mukherji SK. Imaging in pituitary tuberculosis. Clin. Imaging 24(2), 89-92 (2000).
181. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349(16), 1526-1533 (2003).
182. Caturegli P, Lupi I, Landek-Salgado M, Kimura H, Rose NR. Pituitary autoimmunity: 30 years later. Autoimmun. Rev. 7(8), 631-637 (2008).
183. Crock PA, Bensing S, Smith CJA, Burns C, Robinson PJ. Pituitary autoantibodies. Curr. Opin. Endocrinol. Diabet. 13, 344-350 (2006).
184. De Bellis A, Bizzarro A, Bellastella A. Pituitary antibodies and lymphocytic hypophysitis. Best Pract. Res. Clin. Endocrinol. Metab. 19(1), 67-84 (2005).
185. De Bellis A, Bizzarro A, Conte M et al. Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases. J. Clin. Endocrinol. Metab. 88(2), 650-654 (2003). (Pubitemid 36210965)
186. De Bellis A, Salerno M, Conte M et al. Antipituitary antibodies recognizing growth hormone (GH)-producing cells in children with idiopathic GH deficiency and in children with idiopathic short stature. J. Clin. Endocrinol. Metab. 91(7), 2484-2489 (2006). (Pubitemid 44024604)
187. Manetti L, Lupi I, Morselli LL et al. Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non-autoimmune thyroid diseases. J. Clin. Endocrinol. Metab. 92(6), 2176-2181 (2007). (Pubitemid 46997118)
188. De Bellis A, Sinisi AA, Conte M et al. Antipituitary antibodies against gonadotropin-secreting cells in adult male patients with apparently idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 92(2), 604-607 (2007). (Pubitemid 46255302)
189. Hypophysitis research center http://pathology2.jhu.edu/hypophysitis
190. Clinical trials database http://clinicaltrials.gov